Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.

Abstract

RB gene LOH appears to be an early predictive feature for osteosarcomas that indicates a potential unfavorable outcome. RB LOH study might shortly help to identify high-risk patients earlier. If this is verified, therapy could then be adapted earlier to the individual's real risk of relapse.